CardioComm Solutions Inc. (EKG) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.215x

Based on the latest financial reports, CardioComm Solutions Inc. (EKG) has a cash flow conversion efficiency ratio of 0.215x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-121.85K ≈ $-88.15K USD) by net assets (CA$-567.74K ≈ $-410.69K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CardioComm Solutions Inc. market capitalisation for the company's overall valuation and market capitalisation.

CardioComm Solutions Inc. - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how CardioComm Solutions Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

CardioComm Solutions Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CardioComm Solutions Inc. ranked by their cash flow conversion efficiency. Explore CardioComm Solutions Inc. earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
MT Educare Limited
NSE:MTEDUCARE
-0.429x
Protagenic Therapeutics
NASDAQ:PTIX
0.087x
Grupo Vasconia S.A.B
MX:VASCONI
0.006x
Distribution Finance Capital Holdings PLC
LSE:DFCH
0.088x
Ausmon Resources Ltd
AU:AOA
-0.232x
Moab Minerals Ltd
AU:MOM
-0.120x
Jiuzi Holdings Inc
NASDAQ:JZXN
-0.105x
Direct Digital Holdings Inc
NASDAQ:DRCT
0.064x

Annual Cash Flow Conversion Efficiency for CardioComm Solutions Inc. (2013–2024)

The table below shows the annual cash flow conversion efficiency of CardioComm Solutions Inc. from 2013 to 2024. View latest CardioComm Solutions Inc. stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-276.58K
≈ $-200.07K
CA$-110.66K
≈ $-80.05K
0.400x +273.45%
2023-12-31 CA$-504.65K
≈ $-365.06K
CA$-54.07K
≈ $-39.11K
0.107x +180.05%
2022-12-31 CA$-407.32K
≈ $-294.65K
CA$54.52K
≈ $39.44K
-0.134x -146.91%
2021-12-31 CA$-423.38K
≈ $-306.26K
CA$-120.80K
≈ $-87.38K
0.285x +585.41%
2020-12-31 CA$-670.32K
≈ $-484.90K
CA$39.40K
≈ $28.50K
-0.059x -185.08%
2019-12-31 CA$-895.81K
≈ $-648.01K
CA$-61.89K
≈ $-44.77K
0.069x -97.55%
2018-12-31 CA$-68.41K
≈ $-49.49K
CA$-192.53K
≈ $-139.27K
2.814x +572.08%
2017-12-31 CA$489.32K
≈ $353.96K
CA$-291.70K
≈ $-211.01K
-0.596x -102.26%
2016-12-31 CA$-7.74K
≈ $-5.60K
CA$-204.16K
≈ $-147.68K
26.374x +6060.44%
2015-12-31 CA$-687.89K
≈ $-497.61K
CA$-294.50K
≈ $-213.03K
0.428x -44.88%
2014-12-31 CA$-595.83K
≈ $-431.02K
CA$-462.75K
≈ $-334.75K
0.777x -72.03%
2013-12-31 CA$-339.45K
≈ $-245.56K
CA$-942.44K
≈ $-681.75K
2.776x --

About CardioComm Solutions Inc.

V:EKG Canada Health Information Services
Market Cap
$1.43 Million
CA$1.98 Million CAD
Market Cap Rank
#30433 Global
#1535 in Canada
Share Price
CA$0.01
Change (1 day)
+100.00%
52-Week Range
CA$0.01 - CA$0.02
All Time High
CA$0.12
About

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, and HeartCheck SMAR… Read more